The global Space Medicine market size is predicted to grow from US$ 2562 million in 2025 to US$ 5624 million in 2031; it is expected to grow at a CAGR of 14.0% from 2025 to 2031.

Space medicine is a specialized field, which developed from Aerospace medicine, that focuses on the acute medical care of astronauts and spaceflight participants. The spaceflight environment poses many unique stressors to the human body, including G forces, microgravity, unusual atmospheres such as low pressure or high carbon dioxide, and space radiation. Space medicine applies emergency medicine, acute care medicine, critical care medicine, interventional radiology, radiology, austere medicine, and toxicology perspectives treat and prepare for medical problems in space. This expertise is then used to inform vehicle systems design to minimize the risk to human health and performance while meeting mission objectives.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

ReportPrime' newest research report, the “Space Medicine Industry Forecast” looks at past sales and reviews total world Space Medicine sales in 2024, providing a comprehensive analysis by region and market sector of projected Space Medicine sales for 2025 through 2031. With Space Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Space Medicine industry.

This Insight Report provides a comprehensive analysis of the global Space Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity.

This report also analyses the strategies of leading global companies with a focus on Space Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Space Medicine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Space Medicine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity.

With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Space Medicine.

This report presents a comprehensive overview, market shares, and growth opportunities of Space Medicine market by product type, application, key players and key regions and countries.

Segmentation by Type

• Private Aerospace Service
• Non-Private Aerospace Service

Segmentation by Application

• Oncology
• Regeneration Medicine
• Neuro Biology
• Microbiology
• Others

Market by Region

• Americas
• APAC
• Europe
• Middle East & Africa

Company’s Coverage

• Space Pharma
• Biogen
• Amgen
• Merck
• Eli Lilly and Company
• Sanofi
• AstraZeneca
• Novartis
• Kernal Biologics
• RevBio, Inc
• Pluristem
• MEDES

Key Questions Addressed in this Report